ABBOTT LABORATORIES (ABT) Financials
Annual revenue, profitability and per-share results for ABBOTT LABORATORIES, as reported in SEC filings.
Revenue · FY2025
$44.33B
▲ 5.7%YoY
Net income · FY2025
$6.52B
▼ 51.3%YoY
Diluted EPS · FY2025
$3.72
▼ 51.3%YoY
Annual income statement
| Period | Revenue | Net income | Gross profit | Dil. EPS |
|---|---|---|---|---|
| FY2025 | $44.33B | $6.52B | — | $3.72 |
| FY2024 | $41.95B | $13.40B | — | $7.64 |
| FY2023 | $40.11B | $5.72B | — | $3.26 |
| FY2022 | $43.65B | $6.93B | — | $3.91 |
Figures as reported in ABBOTT LABORATORIES's 10-K filings on SEC EDGAR. Fiscal years may differ from calendar years.
Never miss a ABT filing.
Get an email when ABT files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.